Suchergebnisse - "Plummer, Elizabeth R."

PubPharm (10)

1

Therapeutic Potential of Poly(ADP-ribose) Polymerase Inhibitor AG014699 in Human Cancers With Mutated or Methylated BRCA1 or BRCA2

enthalten in: Journal of the National Cancer Institute | 2013

von Drew, Y. | Mulligan, E. | Vong, W. | +9

2

Clinicopathological features of homologous recombination-deficient epithelial ovarian cancers : sensitivity to PARP inhibitors, platinum, and survival

enthalten in: Cancer research | 2012

von Mukhopadhyay, A. | Plummer, E. | Elattar, A. | +8

3

Clinicopathological Features of Homologous RecombinationDeficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum, and Survival

enthalten in: Cancer research | 2012

von Mukhopadhyay, A. | Plummer, E. | Elattar, A. | +8

4

Poly(ADP-ribose) polymerase-1 (PARP-1) pharmacogenetics, activity and expression analysis in cancer patients and healthy volunteers

enthalten in: The Biochemical journal | 2011

von Zaremba, T. | Thomas, H. | Cole, M. | +3

5

Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2

enthalten in: Journal of the National Cancer Institute | 2011

von Drew, Y. | Mulligan, E. | Vong, W. | +9

6

Poly(ADP-ribose) polymerase-1 (PARP-1) pharmacogenetics, activity and expression analysis in cancer patients and healthy volunteers

enthalten in: The biochemical journal | 2011

von Zaremba, T. | Thomas, H. | Cole, M. | +3

7

Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials

enthalten in: Cancer chemotherapy and pharmacology | 2010

von Zaremba, T. | Thomas, H. | Cole, M. | +2

8

Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials

enthalten in: Cancer chemotherapy and pharmacology | 2010

von Zaremba, T. | Thomas, H. | Cole, M. | +2

9

Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials

enthalten in: Cancer chemotherapy and pharmacology | 2010

von Zaremba, T. | Thomas, H. | Cole, M. | +2

10

Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials

enthalten in: Cancer chemotherapy and pharmacology | 2010

von Zaremba, T. | Thomas, H. | Cole, M. | +2

1
[1]